FORMÂ 8.3 - Willis Towers Watson plc
Source: RNS
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
|
Name of person dealing (Note 1) |
J.P. Morgan Securities LLC |
|
Company dealt in |
Willis Towers Watson plc |
|
Class of relevant security to which the dealings being disclosed relate (Note 2) |
US$0.000304635 ordinary shares |
|
Date of dealing |
08 April 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
|
|
Long |
Short |
||||
|
|
Number |
|
(%) |
Number |
|
(%) |
|
(1) Relevant securities |
1,688,168 1.31 |
1,591,072 1.23 |
||||
|
(2) Derivatives (other than options) |
1,495,493 1.16 |
1,528,834 1.19 |
||||
|
(3) Options and agreements to purchase/sell |
|
|
||||
|
Total |
3,183,661 2.47 |
3,119,906 2.42 |
||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
|
Purchase/sale |
Number of relevant securities |
Price per unit (USD)
(Note 5) |
|
Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases
Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales |
51,250 100 200 12 6 688 189 100 100 51
1 11 13 1 460 1 5 7 1 13 9 1 10 10 7 6 6 6 1 8 1 1 2 8 6 4 1 1 2 1 2 2 1 2 2 1 1 2 7 4 2 5 5 1 4 |
237.0700 USD 237.1500 USD 237.1950 USD 237.2700 USD 237.2883 USD 237.2893 USD 237.3170 USD 237.3500 USD 237.3600 USD 238.5975 USD
236.5000 USD 236.8018 USD 236.8077 USD 236.8300 USD 237.0700 USD 237.0800 USD 237.0900 USD 237.0986 USD 237.1300 USD 237.1700 USD 237.1744 USD 237.1800 USD 237.2030 USD 237.2090 USD 237.2500 USD 237.2750 USD 237.2867 USD 237.2883 USD 237.2900 USD 237.2950 USD 237.3000 USD 237.3400 USD 237.3500 USD 237.3513 USD 237.3567 USD 237.5275 USD 237.6700 USD 237.8200 USD 237.8400 USD 237.8500 USD 237.8700 USD 237.8900 USD 237.9000 USD 237.9100 USD 237.9200 USD 237.9300 USD 237.9500 USD 238.0000 USD 238.0086 USD 238.0550 USD 238.0800 USD 238.2320 USD 238.2580 USD 238.3400 USD 238.3900 USD |
(b) Derivatives transactions (other than options transactions)
|
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (USD) (Note 5) |
|
Equity Swap |
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
|
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
|
(ii) Exercising
|
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
|
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) NO
|
Date of disclosure |
09 April 2021 |
|
Contact name |
Alwyn Basch |
|
Telephone number |
0207 742 7407 |
|
If a connected EFM, name of offeree/offeror with which connected |
N/A |
|
If a connected EFM, state nature of connection (Note 10) |
N/A |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
